Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.8 SEK | +2.26% | +3.82% | +13.02% |
Mar. 14 | Stock indexes bullish; Leonardo continues on top | AN |
Mar. 08 | Attendo Wins Swedish Regulatory Nod Team Olivia's Swedish Business Purchase | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.02% | 601M | B- | ||
+0.68% | 99.96B | B- | ||
+22.68% | 87.73B | C+ | ||
+10.63% | 29.33B | C+ | ||
-4.32% | 18.21B | B | ||
-3.49% | 14.51B | A- | ||
+19.46% | 12.22B | B- | ||
+31.42% | 12B | B- | ||
+0.10% | 11.94B | A- | ||
-12.24% | 11.63B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Attendo AB - Nasdaq Stockholm
- Ratings Attendo AB